Syndecan 4, galectin 2, and death receptor 3 (DR3) as novel proteins in pathophysiology of preeclampsia

J Matern Fetal Neonatal Med. 2021 Sep;34(18):2965-2970. doi: 10.1080/14767058.2019.1676410. Epub 2019 Oct 13.

Abstract

Introduction: Preeclampsia has the highest rate of obstetric morbidity and mortality.

Methods: We recruited 21 women with preeclampsia and 27 women with uncomplicated pregnancies. We used a quantitative protein macroarray that allowed for analysis of 40 proteins.

Results: We found a statistically significant increase in the concentration of DR3, LIF and a significant decrease of VEGF, PlGF, syndecan-4 and galectin-2, in the plasma of women with preeclampsia.

Conclusions: There are no previous studies assessing syndecan 4, galectin 2, and DR3 concentrations in women with preeclampsia; Our results indicate these proteins are new factors that play important roles in the immunological pathomechanism of preeclampsia.

Keywords: Angiogenesis; apoptosis; cytokine; immune response; inflammatory factors; placenta; preeclampsia.

MeSH terms

  • Biomarkers
  • Female
  • Galectin 2 / genetics*
  • Humans
  • Placenta Growth Factor
  • Pre-Eclampsia*
  • Pregnancy
  • Receptors, Tumor Necrosis Factor, Member 25 / genetics*
  • Syndecan-4 / genetics*

Substances

  • Biomarkers
  • Galectin 2
  • Receptors, Tumor Necrosis Factor, Member 25
  • Syndecan-4
  • TNFRSF25 protein, human
  • Placenta Growth Factor